FDA Inspection
North Houston Center for Reproductive Medicine dba Hart Fertility CenterNorth Houston Center for Reproductive Medicine dba Hart Fertility Center – FDA Inspection, Oct 23, 2017
Record Details
This FDA Inspection record concerns North Houston Center for Reproductive Medicine dba Hart Fertility Center, with an inspection on October 23, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 23, 2017
- Product Type
- Biologics
View Company Profile
ID · e4a41112-2f40-4e02-a776-025bd074cffe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1029763
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of North Houston Center for Reproductive Medicine dba Hart Fertility Center
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 29, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 27, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for North Houston Center for Reproductive Medicine dba Hart Fertility Center
- FDA Inspection 1162284 - 2022-02-09
- FDA Inspection 898330 - 2014-09-29
- FDA Inspection 751556 - 2011-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.